Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Microbial Therapeutic Market, by Region, 2018-2027 (USD Billion)
1.2.2. Microbial Therapeutic Market, by Source, 2018-2027 (USD Billion)
1.2.3. Microbial Therapeutic Market, by Application, 2018-2027 (USD Billion)
1.2.4. Microbial Therapeutic Market, by End user, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Microbial Therapeutic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Microbial Therapeutic Market Dynamics
3.1. Microbial Therapeutic Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Microbial Therapeutic Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Microbial Therapeutic Market, by Source
5.1. Market Snapshot
5.2. Global Microbial Therapeutic Market by Source, Performance - Potential Analysis
5.3. Global Microbial Therapeutic Market Estimates & Forecasts by Source 2017-2027 (USD Billion)
5.4. Microbial Therapeutic Market, Sub Segment Analysis
5.4.1. Bacteria
5.4.2. Fungi
Chapter 6. Global Microbial Therapeutic Market, by Application
6.1. Market Snapshot
6.2. Global Microbial Therapeutic Market by Application, Performance - Potential Analysis
6.3. Global Microbial Therapeutic Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Microbial Therapeutic Market, Sub Segment Analysis
6.4.1. Metabolic Disorders
6.4.2. Haematological Disorders
6.4.3. Oncology
6.4.4. Immunological Disorders
Chapter 7. Global Microbial Therapeutic Market, by End user

7.1. Market Snapshot
7.2. Global Microbial Therapeutic Market by End user, Performance - Potential Analysis
7.3. Global Microbial Therapeutic Market Estimates & Forecasts by End user 2017-2027 (USD Billion)
7.4. Microbial Therapeutic Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceuticals & Biopharmaceutical Companies
7.4.3. Research & Academic Institutions
Chapter 8. Global Microbial Therapeutic Market, Regional Analysis
8.1. Microbial Therapeutic Market, Regional Market Snapshot
8.2. North America Microbial Therapeutic Market
8.2.1. U.S. Microbial Therapeutic Market
8.2.1.1. Source breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End user breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Microbial Therapeutic Market
8.3. Europe Microbial Therapeutic Market Snapshot
8.3.1. U.K. Microbial Therapeutic Market
8.3.2. Germany Microbial Therapeutic Market
8.3.3. France Microbial Therapeutic Market
8.3.4. Spain Microbial Therapeutic Market
8.3.5. Italy Microbial Therapeutic Market
8.3.6. Rest of Europe Microbial Therapeutic Market
8.4. Asia-Pacific Microbial Therapeutic Market Snapshot
8.4.1. China Microbial Therapeutic Market
8.4.2. India Microbial Therapeutic Market
8.4.3. Japan Microbial Therapeutic Market
8.4.4. Australia Microbial Therapeutic Market
8.4.5. South Korea Microbial Therapeutic Market
8.4.6. Rest of Asia Pacific Microbial Therapeutic Market
8.5. Latin America Microbial Therapeutic Market Snapshot
8.5.1. Brazil Microbial Therapeutic Market
8.5.2. Mexico Microbial Therapeutic Market
8.6. Rest of The World Microbial Therapeutic Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Merck & Co.,Inc.
9.2.3. Valent BioSciences Corp.
9.2.4. GlaxoSmithKline plc
9.2.5. Pfizer Inc.
9.2.6. BioMrieux SA
9.2.7. Ajinomoto Co.Inc.
9.2.8. Sanofi S.A
9.2.9. Novartis AG
9.2.10. NovaDigm Therapeutics
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption